This department is offering grants to establish a national network of research centers focused on developing medical countermeasures for radiation emergencies. The goal is to create products to assess, diagnose, and treat radiation exposure consequences during public health emergencies. The grant aims to develop techniques to measure radiation exposure, study biomarkers for tissue damage and recovery, and improve existing therapies for minimizing tissue damage and enhancing survival. Closing date for applications is May 31, 2019.
Opportunity ID: 312761
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-19-012 |
Funding Opportunity Title: | Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Feb 08, 2019 |
Last Updated Date: | Feb 08, 2019 |
Original Closing Date for Applications: | May 31, 2019 |
Current Closing Date for Applications: | May 31, 2019 |
Archive Date: | Jul 06, 2019 |
Estimated Total Program Funding: | $13,500,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Special district governments Public housing authorities/Indian housing authorities State governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education City or township governments Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support a national network of research centers for development of effective and comprehensive medical countermeasures applicable to all subsets of the civilian population in the event of radiological or nuclear emergencies. Applications are sought that propose multidisciplinary basic and translational research to support the development of new medical products that will assess, diagnose, mitigate and/or treat the short-, delayed- and long-term consequences of radiation exposure during and following a radiation public health emergency (e.g. a radiological/nuclear terrorist incident or accident). The goals of this FOA are to: 1) develop new techniques and devices to measure radiation exposure in the human body; 2) follow biomarkers of tissue damage and recovery; and 3) further develop existing (e.g. products in clinical use) as well as novel therapies to minimize tissue damage, hasten tissue recovery, restore normal physiological function, and improve survival. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-012.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | FORMS-E | PKG00248202 | Apr 30, 2019 | May 31, 2019 | View |
Package 1
Mandatory forms
312761 RR_SF424_2_0-2.0.pdf
312761 PHS398_CoverPageSupplement_4_0-4.0.pdf
312761 RR_OtherProjectInfo_1_4-1.4.pdf
312761 PerformanceSite_2_0-2.0.pdf
312761 RR_KeyPersonExpanded_2_0-2.0.pdf
312761 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
312761 PHS_Additional_IndirectCosts-1.0.pdf
312761 PHS_AssignmentRequestForm_2_0-2.0.pdf